Company intelligence / Profile preview

Iona Mind

London, United Kingdom

Ownership: Private
Employees: ~5
Development stage: Other

Overview

The Iona Mind digital therapeutic demonstrated an 88% reduction in depression severity and 72% reduction in anxiety in published trials. It is implemented in NHS Talking Therapies and through partnerships has shown capacity gains for clinicians and improved outcomes for diverse populations, including chronic disease and cancer patients.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Partnerships

Aptar Digital HealthNHS Talking Therapies (UK NHS)Veteran organizations (UK Office for Veterans’ Affairs)Carbone Cancer Center

Beyond the preview

Go deeper on Iona Mind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iona Mind.

Explore the full profile